Dn B Asset Management As Cara Therapeutics, Inc. Transaction History

Dn B Asset Management As

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 06, 2021	SELL	$12.38 - $29.19 $213,059 - $502,359	-17,210 Closed	0 $0
Q1 2021 Apr 15, 2021	SELL	$15.07 - $21.71 $30,140 - $43,420	-2,000 Reduced 10.41%	17,210 $373,000
Q4 2020 Jan 19, 2021	BUY	$12.72 - $16.16 $244,351 - $310,433	19,210 New	19,210 $290,000

16.4M

55K

500

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

Stay updated on Dn B Asset Management As with notifications on news.